Table I.
Clinical association analysis of miR-345 expression in gastric cancer.
| miR-345 level | ||||
|---|---|---|---|---|
| Clinical features | No. of patients | Low | High | P-value |
| Age (years) | 0.125 | |||
| <50 | 36 | 14 | 22 | |
| ≥50 | 49 | 28 | 21 | |
| Sex | 0.380 | |||
| Male | 51 | 23 | 28 | |
| Female | 34 | 19 | 15 | |
| Size | 0.274 | |||
| <5 cm | 36 | 15 | 21 | |
| ≥5 cm | 49 | 27 | 22 | |
| Lymph node metastasis | <0.001 | |||
| No | 35 | 6 | 29 | |
| Yes | 50 | 36 | 14 | |
| TNM stage | 0.002 | |||
| I–II | 49 | 17 | 32 | |
| III–IV | 36 | 25 | 11 | |
P-value represents Chi-square test for the correlation between miR-345 level and clinical features. P<0.05 indicates miR-345 is closely associated with this clinical feature.